Press Releases from Leaders in Pharmaceutical Business Intelligence (LPBI): FIVE new e-Book in our BioMed e-Series are NOW available for Kindle on Amazon.com

Feeds:: Posts; Comments

« Will President Obama’ s Cancer Immunotherapy Colloquium (dubbed Moonshot) mean Government is Fully Behind the War on Cancer or have we heard this before?

JP Morgan Healthcare Conference: Highlights for Day Three and Day Four »

Press Releases from Leaders in Pharmaceutical Business Intelligence (LPBI): FIVE new e-Book in our BioMed e-Series are NOW available for Kindle on Amazon.com

January 19, 2016 by 2012pharmaceutical

Press Releases from Leaders in Pharmaceutical Business Intelligence (LPBI): FIVE new e-Book in our BioMed e-Series are NOW available for Kindle on Amazon.com

Editor-in-Chief, BioMED e-Series: Aviva Lev-Ari, PhD, RN

2016 WE ARE ON AMAZON.COM

http://www.amazon.com/dp/B00DINFFYC

http://www.amazon.com/dp/B018Q5MCN8

http://www.amazon.com/dp/B018PNHJ84

http://www.amazon.com/dp/B018DHBUO6

http://www.amazon.com/dp/B013RVYR2K

http://www.amazon.com/dp/B012BB0ZF0

http://www.amazon.com/dp/B019UM909A

http://www.amazon.com/dp/B019VH97LU

Leaders in Pharmaceutical Business Intelligence (LPBI) would like to announce the First volume of their BioMedical E-Book Series B: Series B: Frontiers in Genomics Research, Volume One is available for Amazon.com Kindle

Newton, MA — (ReleaseWire) — 01/19/2016 — Leaders in Pharmaceutical Business Intelligence would like to announce the First volume of their BioMedical E-Book Series B: Series B: Frontiers in Genomics Research

Volume I: Genomics Orientations for Individualized Medicine which is now available on Amazon Kindle at

http://www.amazon.com/dp/B018DHBUO6

For more information visit:

http://www.sbwire.com/press-releases/leaders-in-pharmaceutical-business-intelligence-would-like-to-announce-first-volume-of-their-biomedical-e-book-series-b-on-genomics-available-on-amazon-kindle-657796.htm

Leaders in Pharmaceutical Business Intelligence (LPBI) Would Like to Announce Volume III of Their BioMedical E-Book Series E: Patient-Centered Medicine

LPBI Announces New e-Book available on Amazon! Volume Three: Milestones in Physiology & Discoveries in Medicine and Genomics

Newton, MA — (ReleaseWire) — 01/14/2016 — Leaders in Pharmaceutical Business Intelligence would like to announce Volume III of their BioMedical E-Book Series E: Patient-Centered Medicine

Volume Three: Milestones in Physiology & Discoveries in Medicine and Genomics which is now available on Amazon Kindle at

http://www.amazon.com/dp/B019VH97LU

For more information visit:

http://www.sbwire.com/press-releases/leaders-in-pharmaceutical-business-intelligence-would-like-to-announce-volume-iii-of-their-biomedical-e-book-series-e-patient-centered-medicine-657043.htm

Leaders in Pharmaceutical Business Intelligence (LPBI) Would Like to Announce the Second Volume of Their BioMedical E-Book Series A: E-Books on Cardiovascular Diseases

New e-Book Available on Amazon.com! Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation

Newton, MA — (ReleaseWire) — 01/15/2016 — Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation which is now available on Amazon Kindle at

http://www.amazon.com/dp/B018Q5MCN8

For more information visit:

http://www.sbwire.com/press-releases/leaders-in-pharmaceutical-business-intelligence-would-like-to-announce-the-second-volume-of-their-biomedical-e-book-series-a-e-books-on-cardiovascular-diseases-657023.htm

Leaders in Pharmaceutical Business Intelligence (LPBI) Would Like to Announce the Third Volume of Their BioMedical E-Book Series A: E-Books on Cardiovascular Diseases

LPBI Announces New e-Book available now on Amazon.com! Volume Three: Etiologies of Cardiovascular Diseases – Epigenetics, Genetics and Genomics

Newton, MA — (ReleaseWire) — 01/14/2016 — Leaders in Pharmaceutical Business Intelligence would like to announce the Third volume of their BioMedical E-Book Series A: e-Books on Cardiovascular Diseases.

Volume Three: Etiologies of Cardiovascular Diseases – Epigenetics, Genetics and Genomics which is now available on Amazon Kindle at

http://www.amazon.com/dp/B018PNHJ84

For more information visit:

http://www.sbwire.com/press-releases/leaders-in-pharmaceutical-business-intelligence-would-like-to-announce-the-third-volume-of-their-biomedical-e-book-series-a-e-books-on-cardiovascular-diseases-657034.htm

Leaders in Pharmaceutical Business Intelligence (LPBI) announces Amazon e-Book for Kindle Volume Four: Therapeutic Promise: Cardiovascular Diseases, Regenerative & Translational Medicine

LPBI Announces New e-Book available now on Amazon.com! Volume Four: Therapeutic Promise: Cardiovascular Diseases, Regenerative & Translational Medicine

Newton, MA — (ReleaseWire) — 01/15/2016 — Volume Four: Therapeutic Promise: Cardiovascular Diseases, Regenerative & Translational Medicine which is now available on Amazon Kindle at